导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.95% | 1842/4773 |
| 近一周 | -1.85% | 3580/5467 |
| 近一月 | 5.19% | 21/5421 |
| 近一季 | 6.77% | 280/5238 |
| 近半年 | 4.36% | 924/4931 |
| 近一年 | 4.60% | 1652/4400 |
| 近两年 | 42.63% | 1757/2954 |
| 近三年 | 53.36% | 510/2253 |
| 成立以来 | 31.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.87% 2939/4961 |
-8.29% 3871/5312 |
- - |
- - |
| 2025 | 12.07% 2707/4813 |
2.83% 1253/3635 |
12.45% 97/4076 |
-8.66% 4057/4524 |
6.10% 380/4813 |
| 2024 | 42.47% 6/3463 |
10.65% 46/2808 |
7.49% 88/3014 |
13.23% 2213/3129 |
5.79% 574/3463 |
| 2023 | -1.33% 503/2656 |
-2.34% 1963/2280 |
2.54% 133/2385 |
5.27% 94/2515 |
-6.40% 1756/2655 |
| 2022 | -3.56% 68/2207 |
2.36% 55/1919 |
-1.18% 1685/2016 |
-8.17% 175/2113 |
3.82% 633/2208 |
| 2021 | - - |
- - |
- - |
-5.73% 850/1466 |
-0.16% 1207/1822 |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4796 | 32.41% |
| 港股通药 | 0.9109 | 32.37% |
| 万家中证港股通创新药ETF | 1.6293 | 32.25% |
| 景顺长城中证港股通创新药ETF | 1.6918 | 32.17% |
| 天弘恒生沪深港创新药精选50ETF | 0.8599 | 32.08% |
| 港股医疗 | 0.9703 | 31.90% |
| 港医疗 | 0.9212 | 31.83% |
| 港股通医疗ETF工银 | 0.9798 | 31.81% |
| 港股通医疗ETF华宝 | 0.9918 | 31.64% |
| 万家中证港股通创新药ETF发起式联接A | 1.4193 | 31.06% |
| 易方达中证银行ETF VS. 长安沪深300非周期A(740101) |